Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-024337

Eiger BioPharmaceuticals, Inc. · EIGR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Peter Honig
Director
Period of report
Mar 5, 2015
Accepted (ET)
Mar 9, 2015 · 8:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001305253

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMar 5, 2015M2,500$11.30A2,500D
Common StockMar 5, 2015M2,200$11.30A4,700D
Common StockMar 5, 2015S2,500$22.50D2,200D
Common StockMar 5, 2015S2,200$22.29D0D
Common StockMar 6, 2015M5,000$9.58A5,000D
Common StockMar 6, 2015S5,000$25.00D0D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock option (right to buy)F2$11.30Mar 5, 2015M2,500DApr 2, 2014Mar 1, 2024Common Stock2,50020,000D
Stock option (right to buy)F3$11.30Mar 5, 2015M2,200DApr 2, 2014Mar 1, 2024Common Stock2,20017,800D
Stock option (right to buy)F4$9.58Mar 6, 2015M5,000DJun 20, 2014May 19, 2024Common Stock5,00012,800D

Explanation of responses